“These findings may inform shared decision-making about JAKi [JAK inhibitor] use in the pediatric population,” the study authors wrote. “Future studies should evaluate whether these findings ...

American youngster Jak Crawford has inched closer to a Formula 1 drive by stepping up to the role of Aston Martin’s reserve driver. Crawford, 20, joined Aston Martin’s young driver development program ...

Aston Martin has announced that American Formula 2 star Jak Crawford will be the team's third driver for the 2026 Formula 1 season. Crawford will continue the development role he has taken as part of ...

AUSTIN -- Rising American racing star Jak Crawford will drive in first practice for Aston Martin ahead of Formula 1's Mexico City Grand Prix next week. Crawford, 20, will take Lance Stroll's seat in ...

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...

Jak Roberto clarified that he is not courting his "My Father's Wife" co-star Kylie Padilla. The Sparkle star guested on "Fast Talk with Boy Abunda" Friday where he was candidly asked by Tito Boy if he ...

Gabby Concepcion couldn't help but tease 'My Father's Wife' co-stars Kylie Padilla and Jak Roberto over their undeniable closeness on set. Kylie Padilla and Jak Roberto were not spared from the ...

Se smrtí počítám. Zpěvačka Konvičková promluvila o nemoci a snu, který si chce splnit Tisíce řidičů tohle dělají denně: Mechanici jen kroutí hlavou, a vy možná taky Rodiče 27 let věznili dceru v ...

Maddie Fisher is a writer, journalist and game developer. She was born and raised on the east coast, having started working in games journalism over fifteen years ago. She tends to enjoy musical ...

Please provide your email address to receive an email when new articles are posted on . JAK inhibition carried higher malignancy risk vs. biologic DMARDs. Malignancy risk was seen in older patients ...

Some previous studies, including the ORAL Surveillance randomized trial, have shown moderately greater cancer risks with JAK inhibitors versus TNF inhibitors. But some other analyses of real-world ...